Profile
Jon Filderman has held positions as Secretary & Director at Immune Design Corp.
starting in 2019 and as Director at Prometheus Biosciences, Inc starting in 2023.
Jon Filderman active positions
Companies | Position | Start |
---|---|---|
IMMUNE DESIGN CORP | Director/Board Member | 2019-04-01 |
PROMETHEUS BIOSCIENCES, INC. | Director/Board Member | 2023-06-15 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
- Stock Market
- Insiders
- Jon Filderman